| Primary information |
|---|
| CancerPPD ID | 3161 |
| PMID | 23301519 |
| YEAR | 2013 |
| SEQUENCE | RWRWRWRW |
| LENGTH | 8 |
| NAME | linear (RW)4-Dox |
| C-ter Modification | Free |
| N-ter Modification | Free |
| Linear/Cyclic | Linear |
| L/D/Mix | L |
| Non-Natural | Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ] |
| NATURE | Anticancer |
| ACTIVITY | 46-69% antiproliferative activity at 1 µM |
| SOURCE | Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP |
| Cancer Type | Leukemia Cancer |
| ASSAY | MTT/MTS assay |
| Patent ID | None |
| Tissue | Blood |
| CELL LINE | CCRF-CEM |
| TEST TIME | 72 to 120-h |
| Secondary information |
|---|
| STRUCTURE | |
| DSSP states | NA |
| SMILES | NA |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA | NA | NA | NA | NA | NA | NA | NA |
|